Back Guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with Type 2 diabetes and atherosclerotic cardiovascular disease (coronary artery disease, peripheral arterial disease, cerebrovascular disease)
In December 2019 the BCS along with the Association of Clinical Diabetologists, the Renal Association, the Primary Care Cardiovascular Society and the Primary Care Diabetes Society published a memorandum of understanding on joint working. An important part of this collaboration was the production of consensus recommendations on the management of patients living with diabetes, cardiovascular and renal conditions. The joint societies have now produced guidance for non-diabetes specialist physicians and primary care teams on cardiovascular risk optimisation in patients with type 2 diabetes and atherosclerotic cardiovascular disease. Endorsed by the societies and the British Association of Stroke Physicians this document builds on the work of Stephen Wheatcroft and colleagues in Leeds and provides simple guidance on the choice of diabetic drug regimen to maximise cardiovascular risk reduction.
The consensus document can be downloaded as a PDF and we hope that it will prove useful. Further consensus statements will follow, the next to focus on the choice of diabetic regimen in heart failure. We will also shortly be announcing full details of a webinar to be held on the evening of the 16th July on the management of patents with diabetes, cardiac and renal disease that will amplify these themes.